liveonearth: (moon)
EPIGENETICS OF DM2: GLUCOCORTICOID AND VIT D RECEPTORS MEDIATE
ALSO TNF ALPHA OR DEXAMETHASONE INDUCES IR
http://www.nature.com/ncb/journal/v17/n1/full/ncb3080.html
Identification of nuclear hormone receptor pathways causing insulin resistance by transcriptional and epigenomic analysis
Sona Kang, Linus T. Tsai, Yiming Zhou, Adam Evertts, Su Xu, Michael J. Griffin, Robbyn Issner, Holly J. Whitton, Benjamin A. Garcia, Charles B. Epstein, Tarjei S. Mikkelsen & Evan D. Rosen
Nature Cell Biology 17, 44–56 (2015) doi:10.1038/ncb3080
Received 06 August 2014 Accepted Nov 2014 Published online 15 Dec 2014
Abstract
Insulin resistance is a cardinal feature of Type 2 diabetes (T2D) and a frequent complication of multiple clinical conditions, including obesity, ageing and steroid use, among others. How such a panoply of insults can result in a common phenotype is incompletely understood. Furthermore, very little is known about the transcriptional and epigenetic basis of this disorder, despite evidence that such pathways are likely to play a fundamental role. Here, we compare cell autonomous models of insulin resistance induced by the cytokine tumour necrosis factor-α or by the steroid dexamethasone to construct detailed transcriptional and epigenomic maps associated with cellular insulin resistance. These data predict that the glucocorticoid receptor and vitamin D receptor are common mediators of insulin resistance, which we validate using gain- and loss-of-function studies. These studies define a common transcriptional and epigenomic signature in cellular insulin resistance enabling the identification of pathogenic mechanisms.
liveonearth: (moon)
A historical overview of bacteriophage therapy
as an alternative to antibiotics
for the treatment of bacterial pathogens.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916379/

What is Phage (bacteriophage) therapy:
http://www.phagetherapycenter.com/pii/PatientServlet?command=static_phagetherapy&secnavpos=1&language=0

Bacteriophage Therapy at the Phage Therapy Center
in Tbilisi, Republic of Georgia
http://www.phagetherapycenter.com/pii/PatientServlet?command=static_home
liveonearth: (TommyLeeJones_skeptical)
The National Institutes of Health, 10 large drug companies and seven nonprofit organizations announced an unconventional partnership on Tuesday intended to speed up development of drugs to treat Alzheimer’s disease, Type 2 diabetes, rheumatoid arthritis and lupus.

During the course of a five-year, $230 million effort, the participants will share data in regular conference calls and meetings, working together to determine which findings are likely to lead to effective treatments. They will make their findings and data publicly available.


...What concerns me about this is the emphasis on drugs. There are better ways to adjust physiology than taking in foreign substances. And there are more useful things we could study. Like food, and exercise, and how to they affect our biochemical and electrical mileau. Sex, we should throw more money at studying sex and how it affects neurotransmitters. On the effects of chewing gum and on understanding the endocrinology of sexual preference. And on why our hearts slow down as we age, and a million other questions. I'm just curious: I really want to know the answers. I wish that the money spent on medical research was directed more by altruism and less by profit motive.

SOURCE
http://www.nytimes.com/2014/02/05/health/nih-joins-drug-makers-and-nonprofits-on-stubborn-diseases.html
liveonearth: (moon)
Notes on an online lecture by David Perlmutter MD on the effects of grains in the diet on brain function... his book on the same subject is just out.
notes )
liveonearth: (Oprah_shocked)
Fascinating new research uses masses of data from NHANES to find that current cannabis users have less insulin resistance, smaller waists, and higher HDL, than former or non-users.

Notes from study and articles )
liveonearth: (moon)
If Americans snacked only occasionally, and in small amounts, this would not present the enormous problem that it does. But because so much money and effort has been invested over decades in engineering and then relentlessly selling these products, the effects are seemingly impossible to unwind. More than 30 years have passed since Robert Lin first tangled with Frito-Lay on the imperative of the company to deal with the formulation of its snacks, but as we sat at his dining-room table, sifting through his records, the feelings of regret still played on his face. In his view, three decades had been lost, time that he and a lot of other smart scientists could have spent searching for ways to ease the addiction to salt, sugar and fat. “I couldn’t do much about it,” he told me. “I feel so sorry for the public.”

SOURCE
NY Times article on the science behind Addictive Food. For sure, the objective is profits, not health.
http://www.nytimes.com/2013/02/24/magazine/the-extraordinary-science-of-junk-food.html?pagewanted=all&_r=1&
liveonearth: (moon)
WHAT TO DO ABOUT THE RICE FINDING
**eat less rice
**vary rice products with other grains
**eat a varied diet and don't fret
**rinse before cooking
**cook differently: boil in excess water and then strain (removes 30% of inorganic)
**limit cereals to one serving/day esp for babies
**avoid baby formula containing domestic rice
notes )
liveonearth: (elephant on trampoline)
The study in question (Women's Health Study) reaffirmed this association, in this case specifically for postmenopausal females. Certainly other populations are likely to be affected as well.

Nice article here: http://naturalmedicinejournal.com/article_content.asp?edition=1§ion=3&article=330

Physicians are faced with a basic question when making a prescription of any drug to a patient: “What are the risks and benefits of this recommendation?” When it comes to statin drugs, the benefits have been grossly overstated, while the risks have continually been swept under the rug. That discussion is much longer than the space available in this commentary. Suffice it to say that it is important to point out that while statins reduce the heart attack risk in women, they do not appear to affect overall risk of death, possibly because an increased risk for diabetes cancels out the reduced heart attack risk. So, let me focus on the study at hand and try to make sense of such a high risk for diabetes in postmenopausal women using statins.
liveonearth: (Default)
John Hahn DPM ND speaking
Podiatric Medicine-Naturopathic Family Practice
notes include nice overview of common foot conditions
original presentation on 2/8/10, moved forward )
liveonearth: (Default)
Comment on the diabetes "megatrials" from Leszek Czupryniak, President of the Polish Diabetes Professional Association:

The results, as you must have heard and you probably might remember, have been conflicting. In some of the studies, intensive glycemic control provided some benefit, especially in terms of microvascular complications. In other trials, especially in the ACCORD study, intensive glycemic control was clearly detrimental in terms of increasing the risk for macrovascular complications.

The first interpretation of these results was basically unfavorable toward intensive diabetes control. And we diabetologists were afraid for a while that perhaps what we were trying to do on an everyday basis was actually harming our patients. However, by looking in more detail at the results -- and this is the issue largely discussed these days in Dubai -- now we know that one [patient with] diabetes is not equal to another [patient with] diabetes. We should no longer adopt one target for [the whole] diabetes population; we should be able to differentiate among patients.

In my opinion -- but not only mine, it has been a shared view during this meeting -- the final interpretation of these studies is rather striking, because now we clearly know that intensive diabetes control is absolutely beneficial for subjects who have just diabetes with no complications, who are relatively young, and who have had diabetes for a shorter time, less than 5 years.

SOURCE
http://www.medscape.com/viewarticle/755416?src=mp&spon=22
liveonearth: (Default)
Metformin treatment has a TSH-lowering effect in hypothyroid patients with PCOS, both treated with l-thyroxine and untreated

http://www.medscape.com/viewarticle/748073?src=mp&spon=22



Insulin plus elevated LH causes increased Testosterone production in ovary
(Windstar)
liveonearth: (Default)
http://www.medscape.com/viewarticle/745359?src=mp&spon=34
is a review on this study:

Wilson KM, Kasperzyk JL, Rider JR, et al. Coffee consumption and prostate cancer risk and progression in the health professionals follow-up study. J Natl Cancer Inst. 2011;103:876-884. Epub 2011 May 17.

but this study
http://cancerres.aacrjournals.org/content/50/21/6836.short
found no correlation at least for survival of fatal prostate cancer, between coffee drinkers or not.

...and... coffee drinkers have higher testosterone! text here. video at link above. )
liveonearth: (Default)
THE LIST (these items all proven to decrease GI uptake of oral thyroid hormone medications)
coffee-->decreases absorption by about 1/3-->vicious cycle
antacids containing aluminum hydroxide (this is also in the anthrax vaccine)
ferrous sulfate
calcium carbonate
soy protein shakes
raloxifene/evista (pharm for osteoporosis)
chromium picolinate (supp for diabetics)

http://www.denvernaturopathic.com/thyroidinterference.htm
references pulled from DenverNaturopathic link above )

Profile

liveonearth: (Default)
liveonearth

May 2025

S M T W T F S
    123
45678910
11121314151617
1819202122 2324
25262728293031

Syndicate

RSS Atom

Most Popular Tags

Style Credit

Expand Cut Tags

No cut tags
Page generated May. 31st, 2025 07:47 am
Powered by Dreamwidth Studios